InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,898.05
(
-0.50%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.50
(
-2.79%
)
Bitcoin
57,396.66
(
-5.29%
)
Post# of 251668
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119534
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 173700

Tuesday, 02/11/2014 7:27:14 AM

Tuesday, February 11, 2014 7:27:14 AM

Post# of 251668
MNK acquires CADX for $14/sh, a 26% premium to yesterday’s closing price:

http://finance.yahoo.com/news/mallinckrodt-plc-acquire-cadence-pharmaceuticals-120000298.html

CADX’s claim to fame is Ofirmev, an IV formulation of acetaminophen for hospital use. The nominal deal value is $1.3B. MNK was the 2013 pharma spin-off from COV, which was itself spun off from Tyco in 2007.

CC at 8:30am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up